Cargando…

Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis

OBJECTIVE: Previous studies suggest the benefit of dual antiplatelet therapy (DAPT) for acute ischemic stroke with large artery atherosclerosis (LAA) etiology, but there is no study about the effect of DAPT plus anticoagulant in this population. METHODS: A prospective single arm trial was performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao‐Qiu, Hou, Xiao‐Wen, Cui, Yu, Tian, Xiao‐Fu, Wang, Xin‐Hong, Zhou, Zhong‐He, Chen, Hui‐Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304821/ https://www.ncbi.nlm.nih.gov/pubmed/35678020 http://dx.doi.org/10.1002/brb3.2664

Ejemplares similares

Effect of Argatroban Combined With Dual Antiplatelet Therapy on Early Neurological Deterioration in Acute Minor Posterior Circulation Ischemic Stroke
por: Zhou, Ling-Shan, et al.
Publicado: (2020)

Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosis
por: Wang, Peng-Fei, et al.
Publicado: (2021)

Dual versus mono antiplatelet therapy in mild‐to‐moderate stroke during hospitalization
por: Fan, Haimei, et al.
Publicado: (2022)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis
por: Lv, Bin, et al.
Publicado: (2022)

Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study
por: Hou, Xiaowen, et al.
Publicado: (2018)

Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients
por: Liu, Shoufeng, et al.
Publicado: (2020)

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
por: Khazaal, Ossama, et al.
Publicado: (2021)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014)

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging
por: Pei, Lu-lu, et al.
Publicado: (2020)

Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke
por: He, Dan, et al.
Publicado: (2022)

Targeted metabolomics reveals serum changes of amino acids in mild to moderate ischemic stroke and stroke mimics
por: Tao, Shuxin, et al.
Publicado: (2023)

The use of dual antiplatelet therapy for ischemic cerebrovascular events
por: Mele, Francesco, et al.
Publicado: (2022)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis
por: Xie, Wuxiang, et al.
Publicado: (2015)

Progression of Mild to Moderate Stenosis in the Internal Carotid Arteries of Patients With Ischemic Stroke
por: Ong, Cheung-Ter, et al.
Publicado: (2018)

A randomized trial of Trendelenburg position for acute moderate ischemic stroke
por: Chen, Hui-Sheng, et al.
Publicado: (2023)

Safety and efficacy of short-term dual antiplatelet therapy combined with intensive rosuvastatin in acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2023)

Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke
por: Induruwa, Isuru, et al.
Publicado: (2016)

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
por: Zeng, Yan-Ming, et al.
Publicado: (2020)

Study of the Neuroprotective Effects of Memantine in Patients with Mild to Moderate Ischemic Stroke
por: Kafi, Hamidreza, et al.
Publicado: (2014)

Argatroban for an alternative anticoagulant in HIT during ECMO
por: Rougé, Alain, et al.
Publicado: (2017)

Sex Differences in Intracranial Atherosclerosis in Patients With Hypertension With Acute Ischemic Stroke
por: Song, Jae W., et al.
Publicado: (2022)

Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?
por: Balucani, Clotilde, et al.
Publicado: (2010)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
por: Zhong, Jie, et al.
Publicado: (2023)

In-hospital prognosis of first-ever noncardiogenic ischemic stroke in patients with and without indication for prestroke antiplatelet therapy: Chinese Stroke Center Alliance
por: Xu, Yu-Yuan, et al.
Publicado: (2021)

Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
por: Agarwal, Shvetank, et al.
Publicado: (2012)

Reversible Crystallization of Argatroban after Subcutaneous Application in Pigs
por: Lopez, Mercedes, et al.
Publicado: (2012)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

Argatroban Treatment and Decreased Fibrinogen in a Septic Patient
por: Ajmeri, Aman N, et al.
Publicado: (2020)

Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
por: Ma, Yan, et al.
Publicado: (2018)

Advances in Our Understanding of “Resistance” to Antiplatelet Agents for Prevention of Ischemic Stroke
por: Gorelick, Philip B., et al.
Publicado: (2013)

Antiplatelet therapy may be safe in ischemic stroke patients with cerebral microbleed
por: Meng, Ningqin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v74477uo4l5nqc0nntkl7ln8qr